- Home
- TGTX
TGTX
TG Therapeutics Inc.
as 07-26-2024 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as TG Therapeutics Inc. TGTX prepares to release earnings report on 30 Jul 2024.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | N/A | IPO Year: | 1995 |
| Target Price: | $31.20 | AVG Volume (30 days): | 2.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.46 - $23.12 | Next Earning Date: | 07-30-2024 |
| Revenue: | $289,334,000 | Revenue Growth: | 3275.73% |
| Revenue Growth (this year): | 34.77% | Revenue Growth (next year): | 53.01% |
Stock Insider Trading Activity of TG Therapeutics Inc. (TGTX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lonial Sagar | TGTX | Director | Jun 17 '24 | Sell | $16.87 | 16,348 | $275,790.76 | 105,195 | SEC Form 4 |
| Lonial Sagar | TGTX | Director | Jun 17 '24 | Sell | $16.39 | 9,585 | $157,098.15 | 99,293 | SEC Form 4 |
| Lonial Sagar | TGTX | Director | Mar 13 '24 | Sell | $15.94 | 5,000 | $79,675.00 | 108,878 | SEC Form 4 |
| Charney Laurence N | TGTX | Director | Mar 12 '24 | Sell | $15.97 | 22,000 | $351,340.00 | 215,229 | SEC Form 4 |
| Charney Laurence N | TGTX | Director | Jan 5 '24 | Sell | $19.03 | 17,500 | $333,025.00 | 237,229 | SEC Form 4 |
| Power Sean A | TGTX | CFO | Jan 3 '24 | Sell | $16.91 | 47,867 | $809,430.97 | 606,969 | SEC Form 4 |
Latest TG Therapeutics Inc. News
TGTX Breaking Stock News: Dive into TGTX Ticker-Specific Updates for Smart Investing
Investor's Business Daily
14 days ago
Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves
Investor's Business Daily
a month ago
Stocks To Watch: Biotech Leader TG Therapeutics Clears Resistance Area
GuruFocus.com
a month ago
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
2 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Simply Wall St.
2 months ago
American Software Full Year 2024 Earnings: EPS Beats Expectations
Compare TGTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TGTX TG Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.